I upgraded iShares China Large-Cap ETF to Buy, citing robust local capital flows and policy support. FXI offers over 22% consensus upside and a 2% dividend yield, with key holdings out-yielding local ...

A three-decade-old competition that has spawned three Nobel laureates is becoming victim to the chaos at the National Institutes of Health. The Community Wide Experiment on the Critical Assessment of ...

Recent clinical and pre-clinical studies and analysis indicates the potential to increase lifespan and reduce age-associated degeneration in multiple organ systems has be realized with a focus on the ...

If anyone’s found themselves everywhere lately, it’s Paul Mescal. But the Irish actor, fresh off Cannes, where his latest film The History of Sound premiered to a six-minute standing ovation, is now ...

As dissatisfied American parents look for education alternatives in the wake of pandemic-era frustrations with the status quo, the role of the teacher is rapidly evolving, with some private schools ...

For at least the next four games — and potentially several more — the New Orleans Saints are going to have to figure out how to play without one of their best offensive players in Erik McCoy. “He’s an ...

The writing is on the wall for Maxxine Dupri's tenure as Alpha Academy's member in WWE. Chad Gable consistently calls the 27-year-old performer a failure for her inability to be a multi-time ...

Fidelity U.S. Multifactor ETF (FLRG) is seen by the author as a possible alpha-generating fund to possibly complement a core ETF like SPY. Not so far though. FLRG uses four factors: attractive ...

Veteran stockpicker Ben Whitmore is to leave Jupiter to set up his own independent value boutique, the firm announced this morning. He will remain with Jupiter until at least the end of July 2024, the ...

Velmanase alfa is the first and only enzyme replacement therapy for the non-neurological signs and symptoms of mild to moderate alpha-mannosidosis.[1] Alpha-mannosidosis is an extremely rare inherited ...